LivaNova (LIVN) Accumulated Expenses (2015 - 2026)
LivaNova (LIVN) reported Accumulated Expenses of $9.6 million for Q1 2026, down 91.11% on a YoY basis from $108.4 million in Q1 2025, and down 23.18% sequentially from $12.6 million in Q4 2025.
LivaNova (LIVN) Accumulated Expenses (2015 - 2026) Analysis & Trends
LivaNova (LIVN) has 12 years of Accumulated Expenses data on file, last reported at $9.6 million in Q1 2026.
- For the quarter ending Q1 2026, Accumulated Expenses fell 91.11% year-over-year to $9.6 million; the trailing twelve-month figure through Mar 2026 stood at $9.6 million (down 91.11% YoY), and the FY2025 full-year result was $12.6 million, down 2.83% from the prior year.
- Accumulated Expenses retreated to $9.6 million in Q1 2026, from $12.6 million in the prior quarter.
- In the past five years, Accumulated Expenses ranged from a high of $108.4 million in Q1 2025 to a low of $9.6 million in Q1 2026.
- A 5-year average of $60.9 million and a median of $64.7 million in 2024 frame the typical range for Accumulated Expenses.
- Across the five-year window, Accumulated Expenses soared 373.06% in 2024 and slumped 91.11% in 2026, its largest moves.
- Tracing LIVN's Accumulated Expenses over 5 years: stood at $81.5 million in 2022, then soared by 31.69% to $107.3 million in 2023, then tumbled by 87.96% to $12.9 million in 2024, then retreated by 2.83% to $12.6 million in 2025, then slipped by 23.18% to $9.6 million in 2026.
- Business Quant data shows LIVN's Accumulated Expenses at $9.6 million in Q1 2026, $12.6 million in Q4 2025, and $16.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | LivaNova | 4.30 Bn | 3.76 Bn | 243.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.64 Mn |
| Dec 31, 2025 | 12.55 Mn |
| Sep 30, 2025 | 16.50 Mn |
| Jun 30, 2025 | 103.24 Mn |
| Mar 31, 2025 | 108.44 Mn |
| Dec 31, 2024 | 12.92 Mn |
| Sep 30, 2024 | 104.52 Mn |
| Jun 30, 2024 | 64.67 Mn |
| Mar 31, 2024 | 91.35 Mn |
| Dec 31, 2023 | 107.30 Mn |
| Sep 30, 2023 | 89.68 Mn |
| Jun 30, 2023 | 22.35 Mn |
| Mar 31, 2023 | 19.31 Mn |
| Dec 31, 2022 | 81.48 Mn |
| Sep 30, 2022 | 57.74 Mn |
| Jun 30, 2022 | 50.27 Mn |
| Mar 31, 2022 | 82.57 Mn |
| Dec 31, 2021 | 32.85 Mn |
| Sep 30, 2021 | 33.53 Mn |
| Jun 30, 2021 | 62.21 Mn |